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Experimental Details  
Cytotoxic Activity:  
The cytotoxic activity was evaluated by MTT colorimetric assay [1,2]. The sample stock solution (100 
µg/mL) was dissolve in 1% (v/v) DMSO in phosphate buffered saline (PBS). The samples were further 
diluted with DMEM to afford concentration ranging from 100 – 3.13 µg/mL obtained from twofold 
dilution.  The cells were cultured in Dulbecco’s modified Eagle’s Medium (DMEM) media supplemented 
with 10% fetal bovine serum and 2% penicillin-streptomycin. In brief, 90 µL of cell suspension in 
DMEM were seeded in 96-well microplate and was counted directly by using trypan blue dye. The cells 
were treated with samples after reaching confluence (2 x 10
5
 cell/mL) and were pre-incubated at 37ºC in 
humidified atmosphere with 5% CO2 for 24 hours. 20 µL of MTT (5 mg/mL in PBS) was added to all 
well in dark condition and pre-incubated for another 4 hours. 100 µL of DMSO was added to all well to 
solubilize the water-insoluble purple formazan crystal formed and pre-incubated in dark condition at 
room temperature. The absorbance was read after 1 hour at 570 nm and 630 nm as the reference 
wavelength. Untreated cells served as control group and considered as 100% of viable cells. Results were 
expressed as percentage of cell viability of samples relative to the untreated control cell following the 
formula; 
%Inhibition Concentration (%IC) = [(Asample - AMTT blank)/ (Acontrol - AMTT blank)] x 100%%  
where Asample is the absorbance of cells treated with samples, AMTT blank is the absorbance of MTT reagent 
with DMSO only and Acontrol is the absorbance of untreated control cells. 
 
Antibacterial Activity:  
The antibacterial activity of all compounds was tested quantitatively by evaluating their minimum 
inhibition concentration (MIC). The MIC was carried out by micro-broth dilution [3–7]. The sample stock 
solution (1000 µg/mL) was prepared in 5% DMSO in nutrient broth (NB) supplemented with 0.02% (v/v) 
Tween 80. Further twofold dilution with NB was performed to afford concentration of samples from 100 
– 7.81 µg/mL. 50 µL of bacteria inocula (106 CFU/mL) was dispensed in the 96-well microplate followed 
by 50 µL of the sample solution. The microplates were pre-incubated for 24 hour at 37ºC for S. aureus, E. 
coli and P. aeruginosa and 30 ºC for B. subtilis. 25 µL of 2-(4-Iodophenyl)-3-(4-nitrophenyl)-5-phenyl-
2H-tetrazolium (INT) (0.2 mg/mL in distilled water) solution was added to all wells and were further pre-
incubated for at least 30 minutes. Bacteria growth in the wells was indicated by formation of reddish-pink 
colour while clear well indicates inhibition of bacteria growth by the sample. Streptomycin sulphate was 
employed as positive control in this assay.   
 
Statistical Analysis of Data:  
Three replicates of each sample were used for statistical analysis with values reported as mean ± SD. 
Standard curves were generated and calculation of the 50% inhibitory concentration (IC50) values was 
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performed using GraphPad Prism for Windows (version 5.02) software. The Student’s t-test was carried 
out using SPSS (version 22) software to study the comparison between treatment of samples and 
untreated control. A value of p < 0.05 was considered significantly different. 
 
Bar Graph on Cytotoxic Activity of Isoapetalic acid (1) and Apetalic acid (2) against A-549 and 
MCF-7 cell lines at six different concentrations 
 
 
 
Percentage of Inhibition Concentration (%IC) of Isoapetalic acid (1) and Apetalic acid (2) against MCF-7  
 
 
 
 
Percentage of Inhibition Concentration (%IC) of Isoapetalic acid (1) and Apetalic acid (2) against A-549  
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Isoapetalic acid (1): Pale yellow gum; Rf 0.38 (n-Hex:Et2O, 1:1); [α]  -196.7º (c 0.033, CHCl3); IR 
(NaCl disc, CHCl3) υ max cm
-1
: 3405 (OH), 2975 and 2932 (sp
3 
CH), 1707 (C=O acid), 1646 (chelate C=O 
ketone), 1626 and 1580 (C=C aromatic), 1354 and 1190 (C-O); 
1
H NMR (400 MHz, CDCl3): δ 0.88 (3H, 
t, J = 7.2 Hz, H-24), 1.20 (2H, m, H-23), 1.22 (3H, d, J = 7.2 Hz, H-16), 1.42 (3H, s, H-18), 1.46 (3H, s, 
H-17), 1.50 (3H, d, J = 6.4 Hz, H-15), 1.58 (1H, m, H-22α), 1.86 (1H, m, H-22β), 2.55 (1H, dq, J = 10.8 
and 7.2 Hz, H-3), 2.68 (1H, dd, J = 15.6 and 6.8 Hz, H-20α), 2.83 (1H, dd, J = 15.2 and 8.4  Hz, H-20β), 
3.71 (1H, m, H-19), 4.12 (1H, dq, J = 10.8 and 6.4 Hz, H-2), 5.48 (1H, d, J = 10.0 Hz, H-7), 6.62 (1H, d, 
J = 10.0 Hz, H-6) and 12.49 (1H, s, 5-OH); 
13
C NMR (100 MHz, CDCl3): δ 10.5 (C-16), 14.1 (C-24), 
19.5 (C-15), 20.9 (C-23), 28.2 (C-17), 28.4 (C-18), 30.4 (C-19), 35.5 (C-22), 38.6 (C-20), 45.8 (C-3), 
78.1 (C-8), 78.9 (C-2), 101.9 (C-12), 102.6 (C-13), 109.0 (C-10), 115.7 (C-6), 125.6 (C-7), 157.0 (C-5), 
159.9 (C-11 and C-14), 179.0 (C-21) and 199.4 (C-4); EIMS (% rel int): m/z 388 (12), [M]
+
 (C22H28O6), 
373 (100), 329 (5). 
 
 
 
S1: IR spectrum of Isoapetalic acid (1) 
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S2: 
1
H NMR spectrum of Isoapetalic acid (1) 
 
 
 
S3: 
1
H NMR spectrum of Isoapetalic acid (1) (Expansion) 
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S4: DEPTQ spectrum of Isoapetalic acid (1) 
 
 
 
S5: DEPTQ_Q spectrum of Isoapetalic acid (1) 
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S6: EIMS spectrum of Isoapetalic acid (1) 
 
 
 
Apetalic acid (2): Yellow gum; Rf 0.25 (n-Hex:Et2O, 1:1); [α]  -73.4º (c 0.033, CHCl3); IR (NaCl disc, 
CHCl3) υ max cm
-1
: 3423 (OH), 2928 and 2857 (sp
3
 CH), 1705 (C=O acid), 1646 (chelate C=O ketone), 
1626 and 1578 (C=C aromatic), 1215 and 1133 (C-O); 
1
H NMR (400 MHz, CDCl3): δ 0.87 (3H, t, J = 7.2 
Hz, H-24), 1.16 (3H, d, J = 7.2 Hz, H-16), 1.20 (2H, m, H-23), 1.37 (3H, d, J = 6.4 Hz, H-15), 1.38 (3H, 
s, H-18), 1.46 (3H, s, H-17), 1.58 (1H, m, H-22α), 1.86 (1H, m, H-22β), 2.55 (1H, qd, J = 7.2 and 3.2 Hz, 
H-3), 2.66 (1H, dd, J = 15.6 and 6.8 Hz, H-20α), 2.85 (1H, dd, J = 15.2 and 8.4 Hz, H-20β), 3.71 (1H, m, 
H-19), 4.46 (1H, br s, H-2), 5.47 (1H, d, J = 10.0 Hz, H-7), 6.61 (1H, d, J = 10.0 Hz, H-6) and 12.41 (1H, 
s, 5-OH); 
13
C NMR (100 MHz, CDCl3): δ 9.3 (C-16), 14.0 (C-24), 16.3 (C-15), 20.8 (C-23), 28.1 (C-17), 
28.4 (C-18), 30.5 (C-19), 35.5 (C-22), 38.6 (C-20), 44.2 (C-3), 76.1 (C-2), 78.2 (C-8), 101.2 (C-12), 
102.6 (C-13), 108.7 (C-10), 115.6 (C-6), 125.7 (C-7), 157.3 (C-5), 159.9 (C-11 and C-14), 179.4 (C-21) 
and 201.3 (C-4); EIMS (% rel int): m/z 388 (12), [M]
+
 (C22H28O6), 373 (100), 329 (5). 
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S7: IR spectrum of Apetalic acid (2) 
 
 
 
 
S8: 
1
H NMR spectrum of Apetalic acid (2) 
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S9: 
1
H NMR spectrum of Apetalic acid (2) (Expansion) 
 
 
 
S10: DEPTQ spectrum of Apetalic acid (2) 
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S11: DEPTQ_Q spectrum of Apetalic acid (2) 
 
 
 
 
S12: EIMS spectrum of Apetalic acid (2) 
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6-Hydroxy-2-methoxyxanthone (3): Pale yellow solid; Rf 0.45 (n-Hex:EtOAc, 1:1); m.p 263 – 265ºC; IR 
(KBr pellet) υ max cm
-1
: 3423 (OH), 1700 (C=O ketone), 1633 and 1583 (C=C aromatic), 1127 and 1036 
(C-O); 
1
H NMR (400 MHz, CD3COCD3): δ 3.94 (3H, s, 10-OCH3), 6.93 (1H, d, J = 2.4 Hz, H-5), 6.98 
(1H, dd, J = 8.8 and 2.4 Hz, H-7), 7.40 (1H, dd, J = 9.2 and 3.2 Hz, H-3), 7.53 (1H, d, J = 9.2 Hz, H-4), 
7.64 (1H, d, J = 3.2 Hz, H-1), 8.14 (1H, d, J = 8.8 Hz, H-8) and 9.93 (1H, s, 6-OH); 
13
C NMR (100 MHz, 
CD3COCD3): δ 55.3 (C-10), 102.1 (C-5), 106.1 (C-1), 113.8 (C-7), 114.4 (C-8a), 119.2 (C-4), 122.2 (C-
8b), 123.5 (C-3), 128.1 (C-8), 150.7 (C-4a), 156.1 (C-2), 158.0 (C-4b), 163.7 (C-6) and 174.9 (C-9); 
EIMS (% rel int): m/z 242 (100), [M]
+
 (C14H10O4), 227 (24), 212 (31). 
 
 
 
 
S13: IR spectrum of 6-Hydroxy-2-methoxyxanthone (3) 
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S14: 
1
H NMR spectrum of 6-Hydroxy-2-methoxyxanthone (3) 
 
 
 
 
S15: 
1
H NMR spectrum of 6-Hydroxy-2-methoxyxanthone (3) (Expansion) 
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S16: DEPTQ spectrum of 6-Hydroxy-2-methoxyxanthone (3) 
 
 
 
 
S17: DEPTQ_Q spectrum of 6-Hydroxy-2-methoxyxanthone (3) 
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S18: EIMS spectrum of 6-Hydroxy-2-methoxyxanthone (3) 
 
 
 
ent-Epicatechin (4): Pale brown amorphous; Rf 0.25 (n-Hex:EtOAc, 1:1); m.p 235 – 236ºC; [α]  +48.9º 
(c 0.067, MeOH); IR (KBr pellet) υ max cm
-1
: 3455 (OH), 2931 (sp
3
 CH), 1625 (C=C aromatic), 1143 and 
1016 (C-O); 
1
H NMR (400 MHz, CD3COCD3): δ 2.75 (1H, dd, J = 16.8 and 3.2 Hz, H-4α), 2.86 (1H, dd,  
J = 16.8 and 4.4 Hz, H-4β), 3.66 (1H, d, J = 5.6 Hz, 3-OH), 4.22 (1H, br s, H-3), 4.89 (1H, s, H-2), 5.93 
(1H, d, J = 2.4 Hz, H-8), 6.03 (1H, d, J = 2.4 Hz, H-6), 6.79 (1H, d, J = 8.0 Hz, H-5’), 6.85 (1H, dd, J = 
8.0 and 2.0 Hz, H-6’), 7.06 (1H, d, J = 2.0 Hz, H-2’), 7.91 (2H, br s, 3’-OH and 4’-OH), 8.09 (1H, br s, 7-
OH) and 8.26 (1H, br s, 5-OH); 
13
C NMR (100 MHz, CD3COCD3): δ 28.2 (C-4α and C-4β), 66.0 (C-3), 
78.5 (C-2), 94.7 (C-8), 95.3 (C-6), 98.9 (C-4a), 114.4 (C-2’), 114.6 (C-5’), 118.4 (C-6’), 131.3 (C-1’), 
144.4 (C-4’), 144.5 (C-3’), 156.2 (C-8a), 156.6 (C-5) and 156.7 (C-7); EIMS (% rel int): m/z 291 (4) 
[M+H]
+
, m/z 290 (22), [M]
+
 (C15H14O6), 152 (40), 139 (100), 123 (46).  
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S19: IR spectrum of ent-Epicatechin (4) 
 
 
 
 
S20: 
1
H NMR spectrum of ent-Epicatechin (4) 
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S21: 
13
C/DEPT spectra of ent-Epicatechin (4) 
 
 
 
 
S22: EIMS spectrum of ent-Epicatechin (4) 
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Betulinic acid (5): White solid; Rf  0.55 (n-Hex: EtOAc, 3:2); m.p 311 – 313ºC; IR (KBr pellet) υ max cm
-1
: 
3431 (OH), 2943 and 2870 (sp
3
 CH) and 1688 (C=O carboxylic acid); 
1
H NMR (400 MHz, CDCl3): δ 
0.77 (3H, s, H-24), 0.84 (3H, s, H-25), 0.96 (3H, s, H-27), 0.98 (3H, s, H-23), 0.99 (3H, s, H-26), 1.71 
(3H, s, H-30), 3.00 (1H, m, H-19), 3.21 (1H, dd, J = 4.8 and 11.2 Hz, H-3), 4.76 (1H, br s, Ha-29), 4.73 
(1H, br s, Hb-29); 
13
C NMR (100 MHz, CDCl3): δ 14.7 (C-27), 15.4 (C-24), 16.0 (C-25), 16.1 (C-26), 
18.3 (C-6), 19.4 (C-30), 20.9 (C-11), 25.5 (C-12), 27.4 (C-2), 28.0 (C-23), 29.7 (C-21), 30.5 (C-15), 32.2 
(C-16), 34.3 (C-7), 37.0 (C-22), 37.2 (C-10), 38.4 (C-13), 38.7 (C-1), 38.9 (C-4), 40.7 (C-8), 42.4 (C-14), 
46.9 (C-18), 49.2 (C-19), 50.5 (C-9), 55.4 (C-5), 56.3 (C-17), 79.0 (C-3), 109.7 (C-29), 150.4 (C-20), 
179.9 (C-28); EIMS (% rel int): m/z 456 (7) [M]
+
 (C30H48O3), 248 (24), 203 (45), 189 (100). 
 
 
 
S23: IR spectrum of Betulinic acid (5) 
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S24: 
1
H NMR spectrum of Betulinic acid (5) 
 
 
 
 
S25: DEPTQ spectrum of Betulinic acid (5) 
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S26: DEPTQ_Q spectrum of Betulinic acid (5) 
 
 
 
 
S27: EIMS spectrum of Betulinic acid (5) 
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Protocatechuic acid (6): Yellow needle; Rf  0.33 (n-Hex:EtOAc, 1:4); m.p 197 – 198ºC; IR (KBr pellet) υ 
max cm
-1
: 3244 (OH), 1673 (conjugated C=O carboxylic acid), 1617 and 1600 (C=C aromatic) and 1294 
and 1095 (C-O); 
1
H NMR (400 MHz, CD3COCD3): δ 6.91 (1H, d, J = 8.0 Hz, H-6), 7.49 (1H, dd, J = 8.0 
and 2.0 Hz, H-7), 7.54 (1H, d, J = 2.0 Hz, H-3); 
13
C NMR (100 MHz, CD3COCD3): δ 114.8 (C-6), 116.6 
(C-7), 122.2 (C-2), 122.7 (C-3), 144.7 (C-4), 149.9 (C-5) and 166.9 (C-1); EIMS (% rel int): m/z 154 (84) 
[M]
+
 (C7H6O4), 137 (100), 109 (24). 
 
 
 
S28: IR spectrum of Protocatechuic acid (6) 
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S29: 
1
H NMR of Protocatechuic acid (6) 
 
 
 
 
S30: 
13
C/DEPT spectra of Protocatechuic acid (6) 
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S31: EIMS spectrum of Protocatechuic acid (6) 
 
 
Amentoflavone (7): Yellow amorphous; Rf 0.50 (n-Hex:EtOAc, 1:4); m.p 254 – 255ºC; IR (KBr pellet) υ 
max cm
-1
: 3392 (OH), 1651 (chelate C=O ketone), 1609 and 1576 (C=C aromatic) and 1168 and 1111 (C-
O); 
1
H NMR (400 MHz, CD3COCD3): δ 6.26 (1H, d, J = 2.4 Hz, H-6), 6.47 (1H, s, H-6”), 6.54 (1H, d, J 
= 2.0 Hz, H-8), 6.70 (1H, s, H-3”), 6.76 (1H, s, H-3), 6.86 (2H, d, J = 8.8 Hz, H-3”’ and H-5”’), 7.27 (1H, 
d, J = 8.8 Hz, H-5’), 7.69 (2H, d, J = 8.8 Hz, H-2”’ and H-6”’), 8.07 (1H, dd, J = 8.8 and 2.4 Hz, H-6’), 
8.16 (1H, d, J = 2.4 Hz, H-2’), 9.26 (1H, br s, 4’-OH), 9.73 (1H, br s, 4”’-OH), 13.05 (1H, s, 5-OH) and 
13.21 (1H, s, 5”-OH). 13C NMR (100 MHz, CD3COCD3): δ 93.9 (C-8), 98.9 (C-6 and C-6”), 102.9 (C-
3”), 103.4 (C-3), 103.5 (C-8”), 104.5 (C-4a), 104.6 (C-4”a), 115.9 (C-3”’ and C-5”’), 116.6 (C-5’), 119.9 
(C-3’), 122.4 (C-1’), 122.5 (C-1”’), 127.9 (C-6’), 128.3 (C-2”’ and C-6’”), 131.7 (C-2’), 155.2 (C-8”a), 
157.9 (C-8a), 159.4 (C-4’), 161.0 (C-5”), 161.7 (C-5), 161.9 (C-7”), 162.5 (C-4”’), 164.0 (C-2 and C-7), 
164.2 (C-2”), 182.2 (C-4) and 182.6 (C-4”); ESIMS (% rel int): m/z 537 (100) [M-H]+ (C30H18O10). 
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S32: IR spectrum of Amentoflavone (7) 
 
 
 
S33: 
1
H NMR of Amentoflavone (7) 
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S34: 
1
H NMR of Amentoflavone (7) (Expansion) 
 
 
S35: DEPTQ spectra of Amentoflavone (7) 
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S36: DEPTQ-Q spectrum of Amentoflavone (7) 
 
 
 
 
 
S37: ESIMS spectrum of Amentoflavone (7) 
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